American Alpha Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
American Alpha Advisors's PFE Position: Q1 2026 in Review
American Alpha Advisors increased its Pfizer (PFE) stake by 3.2% in Q1 2026, buying an estimated $17.8K and bringing the position to 21,814 shares worth $613K. The position accounts for 0.33% of the portfolio, ranked #54.
American Alpha Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- American Alpha Advisors held 21,814 shares of Pfizer worth $613K as of Q1 2026.
- American Alpha Advisors bought 668 Pfizer shares in Q1 2026, an estimated $17.8K.
- Pfizer made up 0.33% of American Alpha Advisors's portfolio in Q1 2026, its #54 holding.
- American Alpha Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.